1-2 of 2
Tammie Eslinger
Close
Sort by
Journal Articles

Philadelphia Chromosome Negative (Ph-) Very High Risk (VHR) Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents: The Impact of Intensified Chemotherapy on Early Event Free Survival (EFS) in Children’s Oncology Group (COG) Study AALL0031.

Kirk R. Schultz, MD, William Paul Bowman, William Slayton, MD, Alexander Aledo, MD, Meenakshi Devidas, PhD, Harland Sather, PhD, Michael J. Borowitz, MD, PhD, Stella M. Davies, MBBS, PhD, Michael Trigg, MD, Bernice Pasut, RN, Dean Jorstad, RPh, Tammie Eslinger, CCRP, Laura Burden, CCRP, Chenguang Wang, MS, Robert Rutledge, MD, Bruce Camitta, MD, Paul S. Gaynon, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Naomi Winick, MD, Stephen P. Hunger, MD, William L. Carroll, MD
Journal: Blood
Blood (2008) 112 (11): 911.
https://doi.org/10.1182/blood.V112.11.911.911
Published: 2008
Journal Articles

Improved Early Event Free Survival (EFS) in Children with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Intensive Imatinib in Combination with High Dose Chemotherapy: Children’s Oncology Group (COG) Study AALL0031.

Kirk R. Schultz, MD, W. Paul Bowman, MD, William Slayton, MD/PhD, Alex Aledo, MD, Meenakshi Devidas, PhD, Harland Sather, PhD, Michael J. Borowitz, MD/PhD, Stella M. Davies, MD/PhD, Michael Trigg, MD, Bernice Pasut, Dean Jorstad, Tammie Eslinger, Laura E. Burden, Chenguang Wang, PhD, Robert Rutledge, MD, Paul S. Gaynon, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Naomi Winick, MD, Stephen Hunger, MD/PhD, William L. Carroll, MD/PhD, Bruce Camitta, MD/PhD
Journal: Blood
Blood (2007) 110 (11): 4.
https://doi.org/10.1182/blood.V110.11.4.4
Published: 2007